The production of radiopharmaceuticals as compared to traditional pharmaceuticals is a multifaceted procedure and requires specialized facilities, equipment and operational expertise. Further, owing to its inherent hazardous nature, radiopharmaceuticals have a complex regulatory market authorization process. Consequently, a number of innovator companies have demonstrated a preference for outsourcing radiopharmaceutical manufacturing to contract service providers.

To order this 320+ page report, which features 45+ figures and 100+ tables, please visit this - https://www.rootsanalysis.com/reports/nuclear-medicine-and-radiopharmaceuitcals-manufacturing.html

The USD 6+ billion (by 2030) financial opportunity associated with nuclear medicine and radiopharmaceuticals manufacturing, has been analyzed across the following segments:
 Target Disease Indication
 Breast Cancer
 Chronic Lymphocytic Leukemia
 Colorectal Cancer
 Head and Neck Cancer
 Lung Cancer
 Lupus Nephritis
 Melanoma
 Multiple Myeloma
 Primary Sjögren's Syndrome
 Others

 Target Immune Checkpoint
 B7-H3
 CD38
 CD40
 CD47
 Others

 Mechanism of Action
 Inhibitory
 Stimulatory

 Therapeutic Modality
 Monoclonal Antibody
 Small Molecule

 Type of Therapy
 Monotherapy
 Combination Therapy

 Route of Administration
 Intravenous
 Subcutaneous
 Others

 Key Geographical Regions
 North America
 Europe
 Asia-Pacific and the Rest of the World

The Nuclear Medicine and Radiopharmaceuticals Manufacturing Market, 2020-2030” report features the following companies, which we identified to be key players in this domain:
 Advanced Accelerator Applications
 Belgian Nuclear Research Center (SCK•CEN)
 Cardinal Health
 China Isotope & Radiation Corporation
 Curium Pharma
 DuChemBio
 Eckert & Ziegler
 Eczacibasi-Monrol
 GE Healthcare
 Jubilant DraxImage
 Lantheus Medical Imaging
 Nihon Medi-Physics
 Nordion
 PETNET Solutions
 SinoTau Pharmaceuticals
 SOFIE

Table of Contents

1. Preface

2. Executive Summary

3. Introduction

4. Nuclear Medicine and Radiopharmaceuticals Manufacturers (Industry Players): Current Market Landscape

5. Nuclear Medicine and Radiopharmaceuticals Manufacturers (Non-Industry Players): Current Market Landscape

6. Nuclear Medicine and Radiopharmaceuticals Manufacturers in North America

7. Nuclear Medicine and Radiopharmaceuticals Manufacturers in Europe

8. Nuclear Medicine and Radiopharmaceuticals Manufacturers in Asia-Pacific And Rest of The World

9. Nuclear Medicine and Radiopharmaceuticals Manufacturers: Company Competitiveness Analysis

10. Partnerships and Collaborations

11. Production and Supply Chain of Medical Isotope Molybdenum-99 (Technetium-99m)

12. Market Forecast and Opportunity Analysis

13. Concluding Remarks

14. Executive Insights

15. Appendix 1: Tabulated Data

16. Appendix 2: List of Companies and Organizations

To purchase a copy, please visit https://www.rootsanalysis.com/reports/nuclear-medicine-and-radiopharmaceuitcals-manufacturing.html

Contact Details
Gaurav Chaudhary
+1 (415) 800 3415
[email protected]